MarketCap
Xenetic Biosciences XBIO
€ 1.67
-1.06%
Facebook
X
Telegram
Xenetic Biosciences PEG | XBIO
PEG Jährlich Xenetic Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.0129 | -0.0084 | -0.0136 | -0.000647 | 0.0523 | -0.0187 | -0.0099 | 0.0268 | -0.0565 | 0.00393 | 0.00649 | 0.00468 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.0523 | -0.0565 | -0.0022 |
PEG anderer Aktien in der Pharmaeinzelhändler
| Name | PEG | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Neos Therapeutics, Inc.
NEOS
|
-0.0605 | - | -2.54 % | $ 57.2 M |  USA |
 |
Xencor
XNCR
|
0.145 | $ 36.19 | 6.28 % | $ 2.69 B | USA |
 |
Odonate Therapeutics, Inc.
ODT
|
0.464 | - | -3.18 % | $ 58.5 M | USA |
 |
Orphazyme A/S
ORPH
|
-0.0269 | - | -2.25 % | $ 31.3 M |  Danmark |
 |
Osmotica Pharmaceuticals plc
OSMT
|
-0.0466 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
-0.27 | - | - | $ 1.77 B | USA |
 |
Translate Bio, Inc.
TBIO
|
-0.435 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
0.323 | - | - | $ 1.94 B |  Canada |
 |
Exicure
XCUR
|
-0.00217 | $ 0.91 | 2.77 % | $ 5.73 M | USA |
 |
Urovant Sciences Ltd.
UROV
|
208 | - | - | $ 532 M |  Britain |
 |
Acceleron Pharma Inc.
XLRN
|
-4.58 | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
-0.167 | - | 0.52 % | $ 821 M | Danmark |
 |
Zogenix, Inc.
ZGNX
|
-0.0971 | - | -4.97 % | $ 664 M | USA |
 |
Yunhong International
ZGYH
|
0.000875 | - | 0.10 % | $ 92.2 M |  China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
-0.309 | - | -7.58 % | $ 264 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
-0.162 | $ 39.02 | 3.56 % | $ 3.09 B | Canada |
 |
Leap Therapeutics
LPTX
|
-0.00317 | - | 368.57 % | $ 41.9 M | USA |
 |
Zymeworks
ZYME
|
-0.0534 | $ 29.63 | 3.1 % | $ 1.53 B | Canada |
 |
Adial Pharmaceuticals
ADIL
|
-0.000496 | $ 3.15 | -35.42 % | $ 2.11 M | USA |
 |
ADMA Biologics
ADMA
|
0.937 | $ 12.73 | -3.67 % | $ 3.03 B | USA |
 |
Cortexyme
CRTX
|
0.14 | - | -1.05 % | $ 67.1 M | USA |
 |
Burford Capital Limited
BUR
|
0.685 | $ 3.6 | -9.22 % | $ 789 M | Britain |
 |
Daré Bioscience
DARE
|
-0.00777 | $ 0.64 | 2.96 % | $ 7.15 M | USA |
 |
Fate Therapeutics
FATE
|
-1.77 | $ 1.84 | -0.54 % | $ 219 M | USA |
 |
Greenwich LifeSciences
GLSI
|
-0.393 | $ 15.15 | 3.41 % | $ 205 M | USA |
 |
Halozyme Therapeutics
HALO
|
0.872 | $ 103.85 | -15.54 % | $ 12.4 B | USA |
 |
Hutchison China MediTech Limited
HCM
|
-0.44 | $ 15.16 | 6.76 % | $ 13 B | China |
 |
Aptorum Group Limited
APM
|
-0.0451 | - | - | $ 5.72 M | China |
 |
iBio
IBIO
|
-0.0188 | $ 0.74 | 0.77 % | $ 77 M | USA |
 |
Kodiak Sciences
KOD
|
-0.654 | $ 99.33 | 9.13 % | $ 5.29 B | USA |
 |
Karyopharm Therapeutics
KPTI
|
-0 | $ 0.05 | -14.81 % | $ 547 | USA |
 |
FSD Pharma
HUGE
|
0.0115 | - | 5743.5 % | $ 69.7 M | Canada |
 |
BioAtla
BCAB
|
-0.0325 | $ 1.74 | 0.64 % | $ 102 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
0.304 | - | - | $ 3.85 B | USA |
 |
UroGen Pharma Ltd.
URGN
|
0.593 | $ 24.77 | -3.73 % | $ 1.19 B |  Israel |
 |
Catalyst Biosciences
CBIO
|
-0.524 | $ 13.47 | 4.1 % | $ 1.2 B | USA |
 |
ARCA biopharma
ABIO
|
-0.0372 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-0.0483 | - | 4.01 % | $ 150 M | Canada |
 |
ADiTx Therapeutics
ADTX
|
-0 | - | - | $ 374 | USA |
 |
Aeterna Zentaris
AEZS
|
0.00152 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
0.000009 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0122 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | USA |
 |
Aileron Therapeutics
ALRN
|
-0.00319 | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
-5.4 | - | - | $ 5.18 B | USA |
 |
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0 | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
-0 | - | 1083.1 % | $ 745 M | USA |